Bedrocan Cannabis Set to Go Public on August 25, 2014

Bedrocan Cannabis Corp. reiterated that it is expected to start trading on the TSX Venture Exchange on August 25, 2014. It will use the symbol “BED.”

The company also announced the appointment of three independent members to its board of directors.

As quoted in the press release:

Bedrocan’s new independent directors are Mr. Barry Fishman, former CEO of Teva Canada; Mr. Allan Mandelzys, former CEO and senior executive of publicly-traded biotechnology companies; and Mr. Roderick Budd, former life sciences practice leader at Ernst & Young. The new appointees join existing Bedrocan directors Mr. Marc Wayne, President and CEO of Bedrocan, and Chairman of the Board Mr. Murray Goldman, the founder and Chairman of the Goldman Group.

Click here to read the full Bedrocan Cannabis Corp. press release.